Aaron Roberts, MD
Sleep Medicine · Fort Wayne, INNPI 1891088753
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,386 of the $31,103 with a category attached, or 65.5%. 13 manufacturers reported payments, led by Harmony Biosciences LLC at 54.7% of the total. Reporting peaked in 2022 at $10,655 and has fallen 85.6% since, to $1,537 in 2025. Among sleep medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 273 payments — averaging $113.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$17K
- Jazz Pharmaceuticals Inc.$10K
- Inspire Medical Systems, Inc.$3K
- Avadel CNS Pharmaceuticals, LLC$421
- ZOLL Respicardia, Inc.$156
- Eisai Inc.$124
- plus $320 from 7 others
What the payments were for
- Consulting fees$2,5108%
- Speaking & faculty fees$20,38666%
- Travel & lodging$1,2144%
- Food & beverage$6,83822%
- Education$1550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 61 | $17,025 |
| Jazz Pharmaceuticals Inc. | 48 | $10,025 |
| Inspire Medical Systems, Inc. | 143 | $3,032 |
| Avadel CNS Pharmaceuticals, LLC | 7 | $421 |
| ZOLL Respicardia, Inc. | 1 | $156 |
| Eisai Inc. | 1 | $124 |
| Idorsia Pharmaceuticals US Inc | 1 | $122 |
| Axsome Therapeutics, Inc. | 4 | $67 |
| Fisher & Paykel Healthcare Inc | 3 | $58 |
| Itamar Medical Inc | 1 | $23 |
| Johnson & Johnson | 1 | $23 |
| Merck | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wakix$15,589
- XYWAV$8,887
- Inspire$1,090
- Inspire Upper Airway Stimulation System$741
- LUMRYZ$313
- remede System$156
- XYREM$150
- Dayvigo$124
- QUVIVIQ$122
- SUNOSI$111
How this compares
$31,103 in reported general payments places this provider in the 95th percentile of 32 sleep medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| WakixPitolisant Hcl | 27 | $406,807 |
| XywavSodium,calcium,mag,pot Oxybate | 23 | $404,267 |
| Sodium Oxybate | 12 | $221,191 |
| SunosiSolriamfetol Hcl | 21 | $17,977 |
| BelsomraSuvorexant | 18 | $13,371 |
| QuviviqDaridorexant Hcl | 12 | $9,039 |
| DayvigoLemborexant | 19 | $7,393 |
| Armodafinil | 15 | $1,889 |
| Triazolam | 11 | $1,834 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 30 | $1,521 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 38 | $1,287 |
| Quetiapine Fumarate | 28 | $1,273 |
| Trazodone Hcl | 57 | $1,122 |
| Ropinirole Hcl | 88 | $1,027 |
| Doxepin Hcl | 16 | $916 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $17,025 | $406,80727 claims |
| Axsome Therapeutics, Inc.Sunosi | $67 | $17,97721 claims |
| MerckBelsomra | $14 | $13,37118 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $122 | $9,03912 claims |
| Eisai Inc.Dayvigo | $124 | $7,39319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 32 sleep medicine providers in Indiana.
Other sleep medicine in Fort Wayne
- Ram VermaFort Wayne$3K
- Shalini ManchandaIndianapolis$43K
- Sridhar JatlaKokomo$10K
- Douglas LiepertSouth Bend$10K
- Israr SiddiqiElkhart$8K
- Adam LenetIndianapolis$5K
- Alaa ShammahIndianapolis$3K
- Akudo AnokwuteBrownsburg$3K
- Joshua BowlingMishawaka$3K
- Emilee SurvanceSeymour$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.